07:33 AM EST, 11/05/2025 (MT Newswires) -- Royalty Pharma ( RPRX ) reported Q3 net income Wednesday of $288 million, compared with $544 million a year earlier.
Analyst estimates were not readily available for comparison.
Total income and other revenue for the quarter ended Sept. 30 was $609 million, compared with $565 million a year earlier.